Straight talk with...Michel Sidibé

Nair, Prashant
February 2009
Nature Medicine;Feb2009, Vol. 15 Issue 2, p130
Academic Journal
Last month, Michel Sidibé assumed his new role as executive director of UNAIDS, the United Nations agency created more than a decade ago to foster global leadership in the response to the AIDS pandemic. The agency—based in Geneva, Switzerland and cosponsored by ten other UN agencies, including the World Health Organization (WHO) and the World Bank—has received huge praise for helping to increase spending for AIDS and working with civil rights groups to lower the price of antiretroviral drugs. But UNAIDS has also faced criticism for failing to remove legal roadblocks to treatment and prevention of the disease in certain countries and for kowtowing to its cosponsors, which have competed for resources and recognition. Sidibé, a citizen of Mali, joined UNAIDS in 2001. While at the agency, he has overseen and coordinated HIV/AIDS treatment and prevention efforts in UN member countries and implemented methods to evaluate the agency's efforts. Sidibé discussed his new goals as executive director of UNAIDS with Prashant Nair.


Related Articles

  • Global situation of the HIV/AIDS pandemic, end 2003.  // Weekly Epidemiological Record;12/12/2003, Vol. 78 Issue 50, p426 

    Estimates the ARV global treatment needs (2003-2005) under global situation of the HIV/AIDS pandemic at the end of 2003. Information on the effect of the use of antiretroviral therapy (ART); Description of the HIV infection in a patient; Estimate of the treatment needs by the UNAIDS Reference...

  • Progress in global access to HIV/AIDS interventions.  // PharmacoEconomics & Outcomes News;10/17/2009, Issue 589, p2 

    The article reports on the increase in global access to antiretroviral therapy in 2008, according to a joint report from the World Health Organization (WHO), the United Nations Children's Fund and the Joint United Nations Programme on HIV/AIDS. About 42% of HIV patients from low- and...

  • Adult antiretroviral therapy at a glance. Smith, Haley // South African Pharmaceutical Journal;2014, Vol. 81 Issue 9, p27 

    Dealing with the challenges of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) continues to be a major global and regional health priority. According to estimates by the World Health Organization and the Joint United Nations Programme on HIV/AIDS, 35.3-million...

  • TARGETED ACTION ON HIV AND TUBERCULOSIS NEEDED TO REACH DRUG USERS.  // Central European Journal of Public Health;2008, Vol. 16 Issue 4, p204 

    The article reports on guidelines developed and issued by the World Health Organization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS), and the United Nations (UN) Office on Drugs and Crime, which is aimed at reducing preventable deaths by improving access to antiretroviral drugs and...

  • Making Dreams a Reality. Koppal, Tanuja // Drug Discovery & Development;Jul2006, Vol. 9 Issue 7, p4 

    The article discusses the progress of AIDS treatment since the discovery of the disease in 1981. It has been expected that there will be more than 30 drugs available to AIDS patients in the next few years that will improve patient tolerance and compliance. In addition, many programs were...

  • Treating 3 Million HIV-Infected by 2005. Reinhardt, Erika // UN Chronicle;Dec2003-Feb2004, Vol. 40 Issue 4, p64 

    Reports on the 3 by 5 Initiative for the training of community health workers in developing and transition countries to provide anti-retroviral treatment to HIV/AIDS victims by 2005. Program launched by the United Nations World Health Organization (WHO) and the Joint UN Programme on HIV/AIDS...

  • MORE THAN FOUR MILLION HIV-POSITIVE PEOPLE NOW RECEIVING LIFE-SAVING TREATMENT.  // Central European Journal of Public Health;2009, Vol. 17 Issue 4, p178 

    The article focuses on the report "Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector," issued by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF) and the Joint United Nations Programme on HIV/AIDS (UNAIDS), which found that...

  • The "Free by 5" Campaign for Universal, Free Antiretroviral Therapy. Whiteside, Alan; Lee, Sabrina // PLoS Medicine;Aug2005, Vol. 2 Issue 8, p724 

    Focuses on the Free by 5 declaration, a campaign to achieve free access for all individuals with HIV to a medical package including antiretroviral treatment (ART). Problem with user fees for ART in Africa; Origins and objectives of the Free by 5; Arguments about the free treatment of AIDS,...

  • Understanding the Impact of Male Circumcision Interventions on the Spread of HIV in Southern Africa. Hallett, Timothy B.; Singh, Kanwarjit; Smith, Jennifer A.; White, Richard G.; Abu-Raddad, Laith J.; Garnett, Geoff P. // PLoS ONE;2008, Vol. 3 Issue 5, p1 

    Background: Three randomised controlled trials have clearly shown that circumcision of adult men reduces the chance that they acquire HIV infection. However, the potential impact of circumcision programmes - either alone or in combination with other established approaches - is not known and no...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics